We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ALXO market cap is 320.42M. The company's latest EPS is USD -3.0865 and P/E is -1.99.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -32.2M | -36.78M | -53.28M | -48.02M | -37.76M |
| Net Income | -30.18M | -34.16M | -50.99M | -45.47M | -35.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.8M | 1.18M | 0 | 0 | 0 |
| Operating Income | -19.18M | -43.66M | -83.56M | -127.44M | -170.28M |
| Net Income | -23.27M | -50.94M | -83.46M | -123.48M | -160.81M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 278.14M | 245.93M | 220.11M | 242.55M | 212.65M |
| Total Liabilities | 37.75M | 33.24M | 51.36M | 52.84M | 48.46M |
| Total Equity | 240.39M | 212.69M | 168.75M | 189.71M | 164.2M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 10.68M | 436.05M | 380.18M | 306.49M | 242.55M |
| Total Liabilities | 10.95M | 6.21M | 17.13M | 43.03M | 52.84M |
| Total Equity | -70.64M | 429.85M | 363.05M | 263.46M | 189.71M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -27.82M | -59.53M | -90.69M | -130.36M | -37.92M |
| Investing | 42.3M | 48.51M | 61.32M | 44.66M | 26.47M |
| Financing | -107k | 236k | 125k | 59.29M | 3.09M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -14.25M | -38.29M | -68.1M | -89.22M | -130.36M |
| Investing | -353k | 610k | -4.92M | -235.42M | 44.66M |
| Financing | 15.36M | 462.88M | 2.47M | 9.86M | 59.29M |
| Market Cap | 320.42M |
| Price to Earnings Ratio | -1.99 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 14.28 |
| Price to Book Ratio | 1.69 |
| Dividend Yield | - |
| Shares Outstanding | 52.1M |
| Average Volume (1 week) | 1.06M |
| Average Volume (1 Month) | 979.76k |
| 52 Week Change | -12.02% |
| 52 Week High | 17.825 |
| 52 Week Low | 3.9357 |
| Spread (Intraday) | 0.81 (12.84%) |
| Company Name | ALX Oncology Holdings Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.alxoncology.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
